At NRBC, we believe that the most effective and reliable psychopharmacology research is conducted in real clinical settings by practicing psychiatrists with extensive clinical trial expertise.
We are an independent research center, associated with a prominent psychiatric clinical practice, providing the highest quality clinical research care, protocol compliance, and study recruitment in the metro Atlanta area. Our priority is maintaining strict adherence to the FDA Code of Federal Regulations and ICH Guidelines for Good Clinical Practice to assure that patient’s rights as research subjects are protected and that submitted data to sponsors is of the highest quality.
Our medical director, Dr. Michael Banov, is board-certified in adolescent, addiction, and adult psychiatry and is a board certified clinical investigator. He has been involved in clinical drug trial research since his psychiatry training at McLean Hospital, Harvard Medical School. Our full-time research staff includes certified clinical research coordinators with many years of experience in mental health as well as other areas of medicine. They regularly attend continuing education on conducting clinical research studies, GCP guidelines, and mental health updates.
Our center has worked with most of the major central nervous system pharmaceutical companies and contract research organizations. We have participated in Phase II-IV studies in a number of CNS-related therapeutic areas. As an independent site, we are able to work with central Investigational Review Boards.
We are affiliated with Northwest Behavioral Medicine (NBM), one of the largest behavioral health care group practices in Georgia with over 7500 patients. Our psychiatrists are board certified in child, adolescent, addiction, and adult psychiatry and are a major psychopharmacological referral center for physicians and mental health care providers. NBM is well known in the community for providing comprehensive therapies across a number of areas including depression, anxiety, bipolar disorder, schizophrenia, trauma, obsessive-compulsive disorder, eating disorders, and attention deficit disorder.
We take pride in our high standard of care. We also pay particular attention to the care of our patients and their rights as study subjects. Most patients who complete our programs continue in our care for management of their condition. The sponsors of our studies consistently give high marks to our investigators, research coordinators, staff, and facility for the care we provide, customer service to patients and sponsors, and quality of our work.